Medical Condition News

RSS

U.S. FDA grants Veloxis Orphan Drug status for Envarsus

Veloxis Pharmaceuticals A/S, today announced that Envarsus was granted Orphan Drug status by the U.S. Food and Drug Administration (FDA) for prophylaxis of organ rejection in patients receiving allogenic kidney transplants.

24 Dec 2013

Transplanting self-donated Schwann cells aids hind limb functional recovery

A study carried out at the University of Miami Miller School of Medicine for "The Miami Project to Cure Paralysis" has found that transplanting self-donated Schwann cells (SCs, the principal ensheathing cells of the nervous system) that are elongated so as to bridge scar tissue in the injured spinal cord, aids hind limb functional recovery in rats modeled with spinal cord injury.

24 Dec 2013

Changes to LZTR1 gene predispose people to develop schwannomas

Changes to a gene called LZTR1 predispose people to develop a rare disorder where multiple tumors called schwannomas form near nerve pathways, according to a study published today in the journal Nature Genetics and led by researchers from the University of Alabama at Birmingham.

24 Dec 2013

Researchers identify potential therapy for meibomian gland dysfunction

Meibomian gland dysfunction is the leading cause of dry eye disease, which affects tens of millions of Americans. However, there is no FDA-approved treatment for MGD. Researchers from the Schepens Eye Research Institute/Massachusetts Eye and Ear and Harvard Medical School have just identified a potential therapy.

24 Dec 2013

Researchers report new gene delivery method that targets tumor blood vessels

Working in mice, researchers at Washington University School of Medicine in St. Louis report developing a gene delivery method long sought in the field of gene therapy: a deactivated virus carrying a gene of interest that can be injected into the bloodstream and make its way to the right cells.

24 Dec 2013

Most frequent reasons for readmission often related to patients' underlying chronic medical conditions

Researchers cite identification and monitoring of known underlying chronic medical conditions as opportunities to reduce readmission rates and improve patient safety.

24 Dec 2013

Epithelial-to-mesenchymal transition beneficial to cardiac regeneration

Cell-based therapies have been shown to enhance cardiac regeneration, but autologous (patient self-donated) cells have produced only "modest results." In an effort to improve myocardial regeneration through cell transplantation, a research team from Germany has taken epithelial cells from placenta (amniotic epithelial cells, or AECs) and converted them into mesenchymal cells. After transplanting the transitioned cells into mice modelling a myocardial infarction, the researchers found that the epithelial-to-mesenchymal transition was beneficial to cardiac regeneration by lowering infarct size.

24 Dec 2013

New CANHEART health index measures behaviours, health factors for optimal heart health

Fewer than 1 in 10 adult Canadians is in ideal cardiovascular health, according to the new CANHEART health index developed to measure heart health published in CMAJ (Canadian Medical Association Journal).

24 Dec 2013

Research review examines effectiveness of treatments for chronic skin wounds

A systematic review of 66 research papers focused on the treatment of skin ulcers suggests that most are so technically flawed that their results are unreliable. And even of those that pass muster, there is only weak evidence that some treatments work better than standard compression therapy or special stockings.

24 Dec 2013

Research: Beatboxing may be gentler on injury-prone vocal cords

You might think that beatboxing, with its harsh, high-energy percussive sounds, would be harder on the voice than the sweet song of a soprano. But according to new research by voice expert Dr. H. Steven Sims of the University of Illinois Hospital & Health Sciences System, beatboxing may actually be gentler on the injury-prone vocal cords. His findings were published Dec. 23 online in the Journal of Voice.

24 Dec 2013

Inosine drug raises blood and cerebrospinal fluid urate levels in Parkinson disease patients

The drug inosine appears to be a safe and effective way to raise blood and cerebrospinal fluid urate levels in patients with early Parkinson disease, suggesting it may be a potential strategy to slow the disability progression of the degenerative neurological disorder, according to a report published by JAMA Neurology, a JAMA Network publication.

23 Dec 2013

Reflux disease diagnosis: an interview with Professor Peter Dettmar, Managing Director of RD Biomed Limited

Generally speaking, reflux has been a major chronic issue for probably the last 40 or 50 years. When you look at the global population, depending on which country we're talking about, around 20% to 40% of individuals have reflux disease within their populations.

23 Dec 2013

ANP reports positive interim results from ATL1103 Phase II clinical trial for acromegaly

Antisense Therapeutics Limited is pleased to advise that positive results have been achieved from the interim analysis of a subset of available data from its Phase II clinical trial of ATL1103 in patients with the growth disorder, acromegaly.

23 Dec 2013

Can-Fite reports positive results from CF101 Phase IIb study for rheumatoid arthritis

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced results from a 12-week, placebo-controlled Phase IIb study involving 79 patients with active rheumatoid arthritis ("RA") for its proprietary drug CF101, an A3 adenosine receptor ("A3AR") agonist.

23 Dec 2013

European Commission approves update of Erbitux to treat patients with RAS wild-type mCRC

Merck Serono, the biopharmaceutical division of Merck, today announced that the European Commission has approved the Type II variation to amend the Erbitux(cetuximab) product information, updating the indication for Erbitux to the treatment of patients with RAS wild-type metastatic colorectal cancer (mCRC).

23 Dec 2013

Study shows CAC screening plays prominent role in determining person's risk for heart attack and stoke

A new study shows that coronary artery calcium (CAC) screening, an assessment tool that is not currently recommended for people considered at low risk, should play a more prominent role in helping determine a person's risk for heart attack and heart disease-related death, as well as the need for angioplasty or bypass surgery.

23 Dec 2013

Research proves effectiveness of computerized neurocognitive testing for concussions

Computerized neurocognitive testing for concussions is widely used in amateur and professional sports, but little research over the past decade proves its effectiveness, a paper published this month in the journal Neuropsychology Review says.

23 Dec 2013

Breast cancer patients experience fewer side effects on using aromatase inhibitor with sham acupuncture

Breast cancer patients experience fewer side effects while being treated with a widely used drug called an aromatase inhibitor when they get acupuncture - either the real treatment or a "sham" procedure, according to a new study led by researchers at the University of Maryland Marlene and Stewart Greenebaum Cancer Center.

23 Dec 2013

Special combination of yoga and nutrition helps young cancer patients manage disease

At St. Jude Children's Research Hospital, the centuries-old practice of yoga is combined with nutrition education to help young cancer patients manage their disease today and lay the foundation for a healthy future.

23 Dec 2013

Type 2 diabetes in women less than 45 triples risk of early menopause

Type 2 diabetes - the most common type of diabetes - triples the risk of an early menopause in women younger than 45 years of age, according to new research published in the peer-reviewed journal Climacteric.

23 Dec 2013

Medical Condition News

U.S. FDA grants Veloxis Orphan Drug status for Envarsus

Transplanting self-donated Schwann cells aids hind limb functional recovery

Changes to LZTR1 gene predispose people to develop schwannomas

Researchers identify potential therapy for meibomian gland dysfunction

Researchers report new gene delivery method that targets tumor blood vessels

Most frequent reasons for readmission often related to patients' underlying chronic medical conditions

Epithelial-to-mesenchymal transition beneficial to cardiac regeneration

New CANHEART health index measures behaviours, health factors for optimal heart health

Research review examines effectiveness of treatments for chronic skin wounds

Research: Beatboxing may be gentler on injury-prone vocal cords

Inosine drug raises blood and cerebrospinal fluid urate levels in Parkinson disease patients

Reflux disease diagnosis: an interview with Professor Peter Dettmar, Managing Director of RD Biomed Limited

ANP reports positive interim results from ATL1103 Phase II clinical trial for acromegaly

Can-Fite reports positive results from CF101 Phase IIb study for rheumatoid arthritis

European Commission approves update of Erbitux to treat patients with RAS wild-type mCRC

Study shows CAC screening plays prominent role in determining person's risk for heart attack and stoke

Research proves effectiveness of computerized neurocognitive testing for concussions

Breast cancer patients experience fewer side effects on using aromatase inhibitor with sham acupuncture

Special combination of yoga and nutrition helps young cancer patients manage disease

Type 2 diabetes in women less than 45 triples risk of early menopause

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

Latest News